GLAXOSMITHKLINE PLC-SPON ADR

GSK stock holders 13F

5 superinvestors reported owning GSK (ADR) according to the gurus' 2021 Q4 reports.

Top 5 gurus who own (GSK) GLAXOSMITHKLINE PLC-SPON ADR

The 5 super investors (holders) owning GSK (by the percentage (%) of portfolio) are Thomas Graham, Alan, Irving Kahns - Kahn Brothers Group (8.71%), Mark A. Hillman - Hillman Value Fund (3.03%), V. D. Dodge, E. M. Cox - Dodge & Cox Stock Fund (2.73%), B. Tweedy, Ch. Browne - Tweedy, Browne Co All Funds (US) (0.28%) and Sarah Ketterer - Causeway Capital Management (0.17%) as of their 2021 Q4 reports.

To check the latest activities of the top GSK shareholders between value investors, please click on the "Activity" tab.

To see the historical data of GSK's holders please click on the "2021 Q4" dropdown menu and select the date.

# of holders: 5
Period: 2021 Q4
Type: ADR
B. Tweedy, Ch. Browne
0.28%
159,758
$55.13
$8,807,000
+7.53% (+11,185)
+0.02%
Mark A. Hillman
3.03%
119,039
$55.13
$6,562,080
Sarah Ketterer
0.17%
107,127
$55.13
$5,905,500
buy
+0.17%
Thomas Graham, Alan, Irving Kahns
8.71%
909,175
$55.13
$50,118,305
+6.30% (+53,853)
+0.52%
V. D. Dodge, E. M. Cox
2.73%
47,383,018
$55.13
$2,611,988,845
+0.72% (+337,520)
+0.02%
Current price: $33.96 38.40% AVG reported hold price*: $55.13

Completely sold out

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.